Skip to main content
Fig. 6 | Orphanet Journal of Rare Diseases

Fig. 6

From: Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults

Fig. 6

Plasma Lipid Profiles Over Time. Mean baseline values and mean percent changes from baseline are shown for pro-atherogenic (total cholesterol, LDL cholesterol and triglycerides), and anti-atherogenic l (HDL cholesterol) lipids. Data are shown for timepoints at which all five patients had a complete lipid profile

Back to article page